The Leadership
Torge Rempe MD, PhD
- Mailing Address:
-
PO Box 100268
GAINESVILLE FL 32610
- Physical Address:
-
3011 SW WILLISTON RD RM 1103
GAINESVILLE FL 32608
I am an assistant professor with the department of neurology at the University of Florida College of Medicine. Additionally, I am the William T. and Janice M. Neely professor for research in multiple sclerosis. I attended medical school at the Christian-Albrecht University of Kiel in Germany, with one year spent at the University of Murcia in Spain. I graduated with my medical degree in 2012, then pursued my postgraduate neurology training in Germany at the University Hospital of Schleswig-Holstein.
After my preliminary year at SUNY Downstate Medical Center in New York, I completed my neurology residency at the University of Florida. The following year, I finished my clinical neuroimmunology fellowship at the University of California San Diego.
I am board-certified in neurology by the American Board of Psychiatry and Neurology, and I am licensed to practice medicine in both Florida and California. My clinical and research interests include multiple sclerosis, neurosarcoidosis, neuroimmunology, neuromyelitis optica, MOG antibody disease and autoimmune encephalitis. I have contributed to many publications, as well as speak German, English and Spanish.
-
Kenneth M. Heilman Award for Excellence in Research2020 · UF Department of Neurology
-
Program Director’s Award for Academic Excellence2018-2020 · UF Department of Neurology
-
NeurologyAmerican Board of Psychiatry and Neurology
- Neurology
- Multiple sclerosis
- Neurosarcoidosis
- Stroke
- Antibodies
- Multiple Sclerosis
- Neuroimmunology
- Neuroinflammation
- 2024 Magnetic resonance imaging clinics of North America
- 2024 Magnetic resonance imaging clinics of North America
- 2024 Multiple Sclerosis and Related Disorders
- 2023 Medicine
- 2023 Multiple Sclerosis and Related Disorders
- 2022 Frontiers in neurology
- 2022 Annals of clinical and translational neurology
- 2022 Journal of child neurology
- 2021 Multiple Sclerosis and Related Disorders
- 2021 Neurology Neuroimmunology & Neuroinflammation
- 2021 Multiple sclerosis and related disorders
- 2020 Neurology(R) neuroimmunology & neuroinflammation
- 2020 Neuromodulation : journal of the International Neuromodulation Society
- 2020 Journal of neuroimmunology
- 2020 Multiple Sclerosis Journal – Experimental, Translational and Clinical
- 2020 Neuromuscular disorders : NMD
- 2019 European Journal of Neurology
- 2019 Muscle & Nerve
- 2019 Neurology(R) neuroimmunology & neuroinflammation
- 2016 PloS one
- 2016 Parkinsonism & related disorders
- 2015 Journal of magnetic resonance imaging : JMRI
- 2015 Annals of neurology
- 2014 PloS one
-
May 2024
ACTIVE
A Randomized, Double-blind, Phase 3 Study Comparing Efficacy and Safety of Frexalimab (SAR441344) to Placebo in Adult Participants with Nonrelapsing Secondary Progressive Multiple SclerosisSANOFI US SERVICES · Principal Investigator
-
Feb 2023
ACTIVE
CTOA RempeUNIV OF FLORIDA · Principal Investigator
-
Aug 2022
ACTIVE
AGNOS: An 18-month, Open-label, Multi-Center Study to Assess the Effect of Ofatumumab 20mg SC Monthly in Treatment Na?ve, Very Early Relapsing Remitting Multiple Sclerosis Patients Benchmarked Against Healthy Controls on Select OutcomesNOVARTIS PHARMACEUTICALS CORP · Principal Investigator
-
Jun 2022
ACTIVE
A Phase III, Randomized, Double Blind, Placebo controlled, Multi center Study To Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab as Monotherapy or in Addition to Baseline Therapy in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)GENENTECH INC · Principal Investigator
-
May 2022
ACTIVE
A randomized, double-blind, double-dummy, parallel-group study, comparing the efficacy and safety of remibrutinib versus teriflunomide in participants with relapsing multiple sclerosis, followed by extended treatment with open-label remibrutinibNOVARTIS PHARMACEUTICALS CORP · Principal Investigator
-
Apr 2022
ACTIVE
A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with primary progressive multiple sclerosis (PERSEUS)SANOFI · Principal Investigator
-
Mar 2022
–
Aug 2023
A Phase 3, randomized, double-blind efficacy and safety study comparing SAR442168 to teriflunomide (Aubagio) in participants with relapsing forms of multiple sclerosis (GEMINI 2)SANOFI · Principal Investigator
-
Jan 2022
ACTIVE
A PHASE 3B, MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE IMMUNE RESPONSE TO, AND THE SAFETY OF, VACCINES IN PARTICIPANTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS WHO RECEIVE ORAL OZANIMOD COMPARED TO NON-PEGYLATED INTERFERON-B OR NO DISEASE MODIFYING THERAPYPPD INVESTIGATOR SERVICES LLC · Principal Investigator
-
Apr 2019
ACTIVE
TRADITIONAL VERSUS EARLY AGGRESSIVE THERAPY FOR MULTIPLE SCLEROSIS (TREAT-MS) TRIALJOHNS HOPKINS UNIVERSITY · Principal Investigator
-
Jul 2018
ACTIVE
A pragmatic trial to evaluate the intermediate-term effects of early, aggressive versus escalation therapy in people with multiple sclerosisJOHNS HOPKINS UNIVERSITY · Principal Investigator
-
Nov 2017
ACTIVE
CMSC has created the North American Registry for Care and Research in Multiple SclerosisCONSORTIUM OF MS CENTERS · Principal Investigator
-
2020-2021
Fellowship, NeuroimmunologyUniversity of California San Diego
-
2017-2020
Residency, NeurologyUniversity of Florida
-
2005-2012
Medical DegreeChristian-Albrecht University of Kiel
Mayra J Montalvo Perero MD
- Mailing Address:
-
PO Box 100268
GAINESVILLE FL 32610
- Physical Address:
-
3011 SW WILLISTON RD RM 1103
GAINESVILLE FL 32608
My name is Mayra Montalvo Perero, MD, and I am a board-certified neurologist, neurophysiologist and neuroimmunologist at the Norman Fixel Institute for Neurological Diseases at UF Health, serving as an assistant professor in the University of Florida Department of Neurology.
I completed my medical degree in 2010 at the Universidad San Francisco de Quito and my neurology residency in 2019 at Brown University. Following my residency, I completed my clinical neurophysiology fellowship in 2020 at Brown University and my autoimmune neurology fellowship in 2021 at Mayo Clinic in Rochester, Minnesota.
I see patients for a variety of neurological disorders, including multiple sclerosis, neuromyelitis optica, transverse myelitis, optic neuritis, sarcoidosis, autoimmune encephalitis, autoimmune epilepsy and autoimmune ataxias.
Coming from a family of physicians, I was always in awe of how the brain controls everything that happens to our body. I was fascinated about learning the anatomical and physiologic pathway that ruled our every movement.
As a care provider, I believe in advocating for patient care at multiple levels. During my career, I served as a consultant to U.S. congressional representatives as part of the Neurology on the Hill program. In 2019, I founded and worked as the supervising neurologist at Clinica Esperanza, the only community clinic to provide free neurological care for patients without insurance in Rhode Island.
I want all my patients to feel confident that I will provide them with the best care possible. I believe in listening to, and advocating for, my patients every day, and I am honored to be their neurologist.
During my free time, I enjoy spending time with my family, being outdoors and near water, traveling to see the world from different perspectives and dancing (salsa is my favorite!).
-
Abstract merit of distinction2021 · American Academy of Neurology
-
NeurologyAmerican board of Psychiatry and Neurology
- Neurology
- Antibody titer blood test
- Autoimmune disorders
- Central nervous system
- EEG
- Multiple sclerosis
- Optic neuritis
- Transverse myelitis
- Autoimmune encephalitis
- Cerebrovascular diseases
- Intracranial hemorrhage
- Stroke
- Thrombectomy
- 2022 Neurogastroenterology & Motility
- 2022 Epilepsia
- 2015 Journal of the Neurological Sciences
-
2020-2021
Fellowship, Autoimmune NeurologyMayo Clinic
-
2019-2020
Fellowship, Clinical NeurophysiologyBrown University
-
2016-2019
Residency, NeurologyBrown University
-
2010-2013
Medical DegreeUniversidad San Francisco de Quito
-
2006-2010
Bachelor's of ScienceUniversidad San Francisco de Quito